当前位置: 首页 > 详情页

Cochlear Reimplantation Rate and Cause: a 22-Year, Single-Center Experience, and a Meta-Analysis and Systematic Review

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Otolaryngology-Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu, China [2]Department of Otolaryngology-Head and Neck Surgery, XuanWu Hospital of Capital Medical University, Beijing, China
出处:
ISSN:

摘要:
In terms of cochlear reimplantation, there is no consensus on the definition, range, or calculation formulation for the reimplantation rate. This study aims to put forward a relatively standardized and more explicit definition based on a literature review, calculate the rate of cochlear reimplantation, and examine the classification and distribution of the reimplantation causes.A systematic review and retrospective study. A relatively clearer definition was used in this study: cochlear reimplantation is the implantation of new electrodes to reconstruct the auditory path, necessitated by the failure or abandonment of the initial implant. Seven English and Chinese databases were systematically searched for studies published before July 23, 2021 regarding patients who accepted cochlear reimplantation. Two researchers independently applied the inclusion and exclusion criteria to select studies and complete data extraction. As the effect size, the reimplantation rate was extracted and synthesized using a random-effects model, and subgroup and sensitivity analyses were performed to reduce heterogeneity. In addition, a retrospective study analyzed data on cochlear reimplantation in a tertiary hospital from April 1999 to August 2021. Kaplan-Meier survival analysis and the log-rank test were adopted to analyze the survival times of cochlear implants and compare them among different subgroups.A total of 144 articles were included, with 85,851 initial cochlear implantations and 4276 cochlear reimplantations. The pooled rate of cochlear reimplantation was 4.7% [95% CI (4.2% to 5.1%)] in 1989 to 2021, 6.8% [95% CI (4.5% to 9.2%)] before 2000, and 3.2% [95% CI (2.7% to 3.7%)] after 2000 (P=0.003). Device failures accounted for the largest proportion of reimplantation (67.6% [95% CI (64.0% to 71.3%)], followed by medical reasons (28.9% [95% CI (25.7% to 32.0%)]). From April 1999 to August 2021, 1775 cochlear implants were performed in West China Hospital (1718 initial implantations and 57 reimplantations; reimplantation rate 3.3%). In total, 45 reimplantations (78.9%) were caused by device failure, 10 (17.5%) due to medical reasons, and 2 (3.5%) from unknown reasons. There was no difference in the survival time of implants between adults and children (P = 0.558), while there existed a significant difference between patients receiving implants from different manufacturers (P < 0.001).The cochlear reimplantation rate was relatively high, and more attention should be paid to formulating a standard definition, calculation formula, and effect assessment of cochlear reimplantation. It is necessary to establish a sound mechanism for long-term follow-up and rigorously conduct longitudinal cohort studies.Copyright © 2022 The Authors. Ear & Hearing is published on behalf of the American Auditory Society, by Wolters Kluwer Health, Inc.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 1 区 医学
小类 | 1 区 耳鼻喉科学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 听力学与言语病理学 2 区 耳鼻喉科学
JCR分区:
出版当年[2021]版:
Q1 AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY Q1 OTORHINOLARYNGOLOGY
最新[2023]版:
Q1 AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY Q1 OTORHINOLARYNGOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Department of Otolaryngology-Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Otolaryngology-Head and Neck Surgery, West China Hospital of Sichuan University, Chengdu, China [2]Department of Otolaryngology-Head and Neck Surgery, XuanWu Hospital of Capital Medical University, Beijing, China [*1]Department of Otolaryngology- Head and Neck Surgery, West China Hospital of Sichuan University, 37 Guo Xue Lane, Chengdu, Sichuan 610041, People’s Republic of China. [*2]Department of Otolaryngology- Head and Neck Surgery, Hearing Center/Hearing and Speech Science Laboratory, West China Hospital of Sichuan University, 37 Guo Xue Lane, Chengdu, Sichuan 610041, People’s Republic of China. [*3]Department of Otolaryngology- Head and Neck Surgery, XuanWu Hospital of Capital Medical University, No. 45 Changchun St, Xicheng District, Beijing 100053, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17069 今日访问量:2 总访问量:918 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院